Andrew Parratt

Andrew Parratt is currently the QC Manager at Immunodiagnostic Systems (IDS), where they oversee the QC laboratories for product release analysis, raw material analysis, and stability studies. Previously, Andrew served as the QC NPI Team Manager at Fujifilm Diosynth Biotechnologies from 2006 to 2014, leading a team to ensure compliance with cGMP and ICH guidelines. Andrew also completed a Ph.D. at the University of Leeds, researching the use of supercritical carbon dioxide in synthetic chemistry. Their early career included a role as a Synthetic Organic Chemist at Onyx Scientific Ltd, where they synthesized drug product intermediates.